David L Hyslop1, Holly A Read, Daniel N Masica, James G Kotsanos. Show Affiliations » 1. Eli Lilly and Company, Lilly Corporate Center, DC 2520, Indianapolis, Indiana 46285, USA. hyslop_david_l@lilly.com
Abstract
Mesh： See more » HumansPharmacoepidemiologyRiskUnited StatesUnited States Food and Drug Administration
Year: 2002 PMID： 12271886 DOI： 10.1002/pds.757
Source DB: PubMed Journal: Pharmacoepidemiol Drug Saf ISSN： 1053-8569 Impact factor: 2.890